Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain; CIBERfes, Madrid, Spain.
Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.
Mech Ageing Dev. 2019 Jan;177:30-36. doi: 10.1016/j.mad.2018.03.008. Epub 2018 Mar 21.
SOX2 (Sex-determining region Y box 2) is a transcription factor expressed in several foetal and adult tissues and its deregulated activity has been linked to chronic diseases associated with ageing. Nevertheless, the level of SOX2 expression in aged individuals at the tissue level has not previously been examined. In this work, we show that SOX2 expression decreases significantly in the brain with ageing, in both humans and rodents. The administration of resveratrol for 6 months in mice partly attenuated this reduction. We also identified an age-related decline in SOX2 mRNA and protein expression in several other organs, namely, the lung, heart, kidney, spleen and liver. Moreover, peripheral blood mononuclear cells (PBMCs) from elderly expressed lower levels of SOX2 than those from young individuals. Mechanistically, SOX2 expression inversely correlates with p16 levels. Together, these data show a widespread decrease in SOX2 with age, suggesting that the decline in SOX2 expression might be used as a biomarker of ageing.
SOX2(性别决定区 Y 框 2)是一种在几种胎儿和成体组织中表达的转录因子,其活性失调与衰老相关的慢性疾病有关。然而,以前并没有在组织水平上检查过衰老个体中 SOX2 的表达水平。在这项工作中,我们表明 SOX2 的表达在人类和啮齿动物的大脑中随着年龄的增长而显著下降。用白藜芦醇治疗 6 个月在一定程度上减轻了这种减少。我们还在其他几个器官(肺、心脏、肾脏、脾脏和肝脏)中鉴定到与年龄相关的 SOX2 mRNA 和蛋白质表达下降。此外,老年人的外周血单核细胞(PBMC)表达的 SOX2 水平低于年轻人。从机制上讲,SOX2 的表达与 p16 的水平呈反比。总之,这些数据显示 SOX2 随年龄的广泛下降,表明 SOX2 表达的下降可能被用作衰老的生物标志物。